Skip to content
Screener

Staar Surgical STAA Total Equity

Total Equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$2.06B-74.0%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$10.79M+149%
IAR
Integra LifeSciencesIART
$1.04B+0.5%
Schering-Plough logo
Schering-PloughSGP
$250.11M+463%
Glaukos logo
GlaukosGKOS
$682.49M-10.8%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.15B-13.0%
Enterprise value$1.06B-11.7%
P/S-1.9×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemApril 3, 2026January 2, 2026
Stockholders’ equity:
Common stock, $0.01 par value; 60,000 shares authorized: 50,156 shares issued and 49,780 shares outstanding at April 3, 2026 and 49,779 shares issued and 49,403 outstanding at January 2, 2026502498
Additional paid-in capital507,921504,682
Treasury stock, 376 and 376 shares at April 3, 2026 and January 2, 2026, respectively(6,461)(6,461)
Accumulated other comprehensive loss(6,778)(6,511)
Accumulated deficit(142,818)(148,024)
Total stockholders’ equity352,366344,184
Total liabilities and stockholders’ equity$451,118$451,678

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's total equity?
Staar Surgical (STAA) reported total equity of $352.37M in Q1 2026.
How has Staar Surgical's total equity changed year-over-year?
Staar Surgical's total equity increased by 0.7% year-over-year, from $349.97M to $352.37M.
What is the long-term trend for Staar Surgical's total equity?
Over 5 years (2020 to 2025), Staar Surgical's total equity has grown at a 11.8% compound annual growth rate (CAGR), from $197.22M to $344.18M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Staar Surgical's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude